🇺🇸 FDA
Patent

US 10493069

Methods of treating behavioral syndromes using pipradrol

granted A61KA61K31/4458A61K45/06

Quick answer

US patent 10493069 (Methods of treating behavioral syndromes using pipradrol) held by OVID THERAPEUTICS INC. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4458, A61K45/06, A61P, A61P25/00